Trials / Unknown
UnknownNCT04512898
Helicobacter Pylori Eradication and Irritable Bowel Syndrome: A Prospective Study
Effect of Helicobacter Pylori Eradication on Symptoms and Quality of Life of Irritable Bowel Syndrome: A Prospective Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
H. Pylori is frequently observed in patients with irritable bowel syndrome(IBS). However, the effect of H. pylori eradication on IBS is not clear.
Detailed description
Patients with IBS symptoms using Rome IV criteria will be included. Testing for H. pylori will be done. Patients with H. pylori will receive triple therapy and followed after two weeks for eradication and assessment of IBS symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Triple therapy for H.pylori | Triple therapy of proton pump inhibitors, clarithromycin and metronidazole. |
Timeline
- Start date
- 2020-08-10
- Primary completion
- 2020-11-10
- Completion
- 2020-11-10
- First posted
- 2020-08-14
- Last updated
- 2020-08-14
Source: ClinicalTrials.gov record NCT04512898. Inclusion in this directory is not an endorsement.